검색
Repare Therapeutics Inc
RPTX관심 목록에 추가
2.650USD
0.0000.00%
종가 07/02, 13:00（ET）시세는 15분 지연됩니다
114.24M시가총액
손실P/E TTM
자세한 내용은 Repare Therapeutics Inc 회사
Repare Therapeutics Inc. is a clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Its pipeline includes RP-3467, a Phase 1 Polo ATPase inhibitor; RP-1664, a Phase 1 PLK4 inhibitor, and lunresertib, a PKMYT1 inhibitor.
Repare Therapeutics Inc 정보
종목 코드 RPTX
회사 이름Repare Therapeutics Inc
상장일Jun 19, 2020
CEOForte (Steve)
직원 수129
유형Ordinary Share
회계 연도 종료Jun 19
주소7210 Frederick-Banting, Suite 100
도시ST-LAURENT
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Canada
우편 번호H4S 2A1
전화18574127018
웹사이트https://www.reparerx.com/
종목 코드 RPTX
상장일Jun 19, 2020
CEOForte (Steve)
Repare Therapeutics Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Michael Zinda, Ph.D.
Dr. Michael Zinda, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
48.78K
--
Mr. Steve Forte
Mr. Steve Forte
President, Chief Executive Officer, Chief Financial Officer, Director
President, Chief Executive Officer, Chief Financial Officer, Director
25.28K
--
Ms. Sandra Alves
Ms. Sandra Alves
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
12.82K
-146.62%
Ms. Carol Anne Schafer
Ms. Carol Anne Schafer
Independent Director
Independent Director
--
-100.00%
Dr. David P. Bonita, M.D.
Dr. David P. Bonita, M.D.
Independent Director
Independent Director
--
--
Dr. Samarth Kulkarni, Ph.D.
Dr. Samarth Kulkarni, Ph.D.
Independent Director
Independent Director
--
--
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
--
-100.00%
Mr. Thomas Civik
Mr. Thomas Civik
Independent Chairman of the Board
Independent Chairman of the Board
--
-100.00%
Dr. Susan M. Molineaux, Ph.D.
Dr. Susan M. Molineaux, Ph.D.
Independent Director
Independent Director
--
--
Dr. Steven H. Stein, M.D.
Dr. Steven H. Stein, M.D.
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Michael Zinda, Ph.D.
Dr. Michael Zinda, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
48.78K
--
Mr. Steve Forte
Mr. Steve Forte
President, Chief Executive Officer, Chief Financial Officer, Director
President, Chief Executive Officer, Chief Financial Officer, Director
25.28K
--
Ms. Sandra Alves
Ms. Sandra Alves
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
12.82K
-146.62%
Ms. Carol Anne Schafer
Ms. Carol Anne Schafer
Independent Director
Independent Director
--
-100.00%
Dr. David P. Bonita, M.D.
Dr. David P. Bonita, M.D.
Independent Director
Independent Director
--
--
Dr. Samarth Kulkarni, Ph.D.
Dr. Samarth Kulkarni, Ph.D.
Independent Director
Independent Director
--
--
자주 묻는 질문
Repare Therapeutics Inc의 상위 5대 주주는 누구인가요?
Repare Therapeutics Inc의 상위 5대 주주는 다음과 같습니다: Dr. Michael Zinda, Ph.D.
Repare Therapeutics Inc(RPTX)의 주식을 보유한 기관은 몇 개입니까?
2025Q4 기준으로, Repare Therapeutics Inc의 주식을 보유한 기관은 총 116곳이며, 이들이 보유한 주식의 총 가치는 약 24.72M로 전체 발행 주식의 57.35%를 차지합니다. 이는 2025Q3 대비 -9601917.00 증가한 수치입니다.